Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dipyridamole and Magnesium for Sickle Cell Hydration
NCT00276146Phase 2Withdrawn
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- May 2005
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dipyridamole, magnesium in sickle cell anemia (SCA), sponsored by Cincinnati Children's Hospital Medical Center. Planned start May 2005; status: withdrawn.
02
Drugs
dipyridamolemagnesium
03
Conditions
sickle cell anemia (SCA)
Beyond the preview
Go deeper on NCT00276146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276146.